India Emerges as High-Velocity Biopharma Innovation Hub: Endiya Report
India’s biopharma sector gains momentum as policy support, innovation and cost advantages position the country as a global R&D hub.
Global Healthcare Innovation | 31/03/2026 | By News Bureau | 106
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy